Site US10004 is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Site US10004 has participated in 1 clinical trials.
Therapeutic areas: Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations.
Sponsors: Astellas Pharma Global Development, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site US10004 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site US10004 has 1 clinical trials on record. Their work covers Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations.
Site US10004 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.